Abstract
This paper describes the synthesis of 3-methyl-1-morpholin-4-ylmethyl-2,6-diphenylpiperidin-4-one from 3-methyl-2,6-diphenylpiperidin-4-one. The synthesized compound was characterized by FT-IR, 1H NMR, EI-MS and elemental analysis.
Introduction
Compounds with a piperidin-4-one nucleus have received extensive attention in the past and recent years because of their diverse biological activities, including antiviral [1], antitumor [2], central nervous system stimulant [3], analgesic [4], anticancer [5] and antimicrobial activity [6]. Morpholine is a compound widely used in synthesis because of its various industrial applications. In this paper, we want to report the synthesis of 3-methyl-1-morpholin-4-ylmethyl-2,6-diphenylpiperidin-4-one.

Synthesis
Preparation of 3-methyl-1-morpholin-4-ylmethyl-2, 6-diphenylpiperidin-4-one 2
3-Methyl-2,6-diphenylpiperidin-4-one 1 (1.32 g, 0.005 mol), prepared according to the reported literature [7] and formaldehyde (3 mL) were dissolved in a mixture of ethanol (25 mL) and DMF (10 mL). The contents were warmed on a water bath maintained at 60 °C and morpholine (1 mL, 0.01 mol) was added with constant stirring. It was shaken well for an hour. The mixture was poured into crushed ice with constant stirring and kept overnight at room temperature. The precipitate obtained was filtered and dried. The crude sample 2 was recrystallized from absolute ethanol. The yield of the product is 72%.
Melting point: sublimation at 92-94 °C
IR (KBr pellet, cm−1): 1722 (C=O), 1523 (C=C str.), 1222 (C-O-C) (morpholine), 2889 (C-H str.)
1H NMR (300 MHz, CDCl3): 1.71 (s, 3H, CH3), 2.45 (t, J = 7.3 Hz, 4H, morpholine-CH2), 3.61 (t, J = 6.4 Hz, 4H, morpholine-CH2) 4.12 (d, J = 3.6 Hz, 1H, CH), 3.47 (s, 2H, N-CH2-N), 7.08-7.30 (m, 10H, phenyl-H).
Mass (m/z): 364 (M+; 15%), 100 (100%)
Elemental analysis: Calculated: C, 75.79; H, 7.74; N, 7.69; Observed: C, 75.70; H, 7.69; N, 7.71.
Supplementary materials
Supplementary File 1Supplementary File 2Supplementary File 3Acknowledgement
The authors wish to thank the management of SRM University for their moral support.
References
- El-Subbagh, H.I.; Abu-Zaid, S.M.; Mahran, M.A.; Badria, F.A.; Alofaid, A.M. J. Med. Chem. 2000, 43, 2915. [CrossRef]
- Watson, A.A.; Fleet, G.W.J.; Asano, N.; Molyneux, R.J.; Nugh, R.J. Phytochemistry 2001, 56, 265. [PubMed]
- Ganellin, C.R.; Spickett, R.G. J. Med. Chem. 1965, 8, 619. [CrossRef]
- Hagenbach, R.E.; Gysin, H. Experimentia 1952, 8, 184.
- Ileana, B.; Dobre, V.; Nicluescu-Duvaz, I. J. Prakt. Chem. 1985, 327, 667.
- Mokio, I.G.; Soldatenkov, A.T.; Federov, V.O.; Agreev, E.A.; Sergeeva, N.D.; Lin, S.; Stashenku, E.E.; Prostakov, N.S.; Andreeva, E.L. Khim. Farm. Zh. 1989, 23, 421.
- Noller, C.R.; Baliah, V. J. Chem. Soc. 1948, 70, 3853. [CrossRef]
© 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).